Description
A water-soluble derivative of geldanamycin which potently inhibits Hsp90 (IC50 = 24 nM) and has excellent bioavailability and tissue distribution in animals; has diverse anti-tumor actions; suppresses inflammation by interfering with signaling through the NF-κB pathway; ameliorates high fat diet-induced renal failure
Formal name: 17-demethoxy-17-[[2-(dimethylamino)ethyl]amino]-geldanamycin
Synonyms: Alvespimycin|KOS-1022|NSC 707545
Molecular weight: 616.8
CAS: 467214-20-6
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Heat Shock Proteins||Research Area|Cancer||Research Area|Cell Biology|Cell Signaling|NF-κB Signaling||Research Area|Cell Biology|Cellular Chaperones||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Epigenetics, Transcription, & Translation|Transcription Factors||Research Area|Immunology & Inflammation||Research Area|Neuroscience